Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant and Cell Therapy”

1,890 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,890 results

Not applicableStudy completedNCT04922970
What this trial is testing

Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.

Who this might be right for
Stem Cell TransplantLate EffectMetabolic Syndrome+1 more
Rigshospitalet, Denmark 28
Not applicableLooking for participantsNCT07053254
What this trial is testing

The Characteristics and Treatment Mechanism of Vascular Grafts in Elderly Patients With CAOD Through Single-cell Transcriptome Analysis

Who this might be right for
Coronary Artery Occlusive Disease (CAOD)
Yonsei University 100
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Not applicableStudy completedNCT01487031
What this trial is testing

Music Therapy on Nausea and Pain for Autologous Stem Cell

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Lymphoma
Case Comprehensive Cancer Center 108
Early research (Phase 1)Ended earlyNCT01801046
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+24 more
University of Southern California 10
Early research (Phase 1)Ended earlyNCT00058773
What this trial is testing

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Who this might be right for
Hodgkin DiseaseNon-Hodgkins Lymphoma
Baylor College of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT00001566
What this trial is testing

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Who this might be right for
Ewing's SarcomaRhabdomyosarcoma
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Not applicableNo Longer AvailableNCT00720603
What this trial is testing

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Ended earlyNCT01746173
What this trial is testing

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Who this might be right for
T-cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 5
Not applicableActive Not RecruitingNCT05145062
What this trial is testing

Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.

Who this might be right for
Blood and Lymphatic Diseases
Sangamo Therapeutics 8
Early research (Phase 1)UnknownNCT03655795
What this trial is testing

Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD

Who this might be right for
COPD
Ruijin Hospital 20
Large-scale testing (Phase 3)Study completedNCT00022737
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Not applicableLooking for participantsNCT06650553
What this trial is testing

Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

Who this might be right for
Aplastic Anemias
Shanxi Bethune Hospital 110
Testing effectiveness (Phase 2)UnknownNCT05137886
What this trial is testing

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRelapseRefractory Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 47
Testing effectiveness (Phase 2)Study completedNCT01013194
What this trial is testing

Human Fetal Liver Cell Transplantation in Chronic Liver Failure

Who this might be right for
Liver Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies 25
Large-scale testing (Phase 3)Study completedNCT02181413
What this trial is testing

Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Takeda 656
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Testing effectiveness (Phase 2)Study completedNCT01007292
What this trial is testing

YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Who this might be right for
Non-Hodgkin's Lymphoma
Astellas Pharma Inc 43
Next Page